Patents by Inventor Lene Hørlyck

Lene Hørlyck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of quality control testing a Factor XIII containing sample
    Patent number: 9080200
    Abstract: The invention relates to a method of quality control testing a Factor XIII (FXIII) containing sample which comprises the step of detecting the presence of and/or measuring the concentration of pre-activated FXIII (FXIIIao) in said sample and to a quality control kit for determining the quality of a Factor XIII (FXIII) containing sample. Preferably, an anion-exchange chromatographic column is used, as well as the fluorescent substrate Abz-NE (Cad-Dnp) EQVS PLTLLK-OH.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: July 14, 2015
    Assignee: Novo Nordisk Healthcare A/G
    Inventors: Mette Dahl Andersen, Gunhild K. Kristiansen, Pernille Charlotte Svane, Lene Hørlyck, Mette Schrøder
  • Method of Quality Control Testing a Factor XIII Containing Sample
    Publication number: 20110265557
    Abstract: The invention relates to a method of quality control testing a Factor XIII (FXIII) containing sample which comprises the step of detecting the presence of and/or measuring the concentration of pre-activated FXIII (FXIIIao) in said sample and to a quality control kit for determining the quality of a Factor XIII (FXIII) containing sample. Preferably, an anion-exchange chromatographic column is used, as well as the fluorescent substrate Abz-NE (Cad-Dnp) EQVS PLTLLK-OH.
    Type: Application
    Filed: October 23, 2009
    Publication date: November 3, 2011
    Applicant: Novo Nordisk Health Care AG
    Inventors: Mette Dahl Andersen, Gunhild K. Kristiansen, Pernille Charlotte Svane, Lene Hørlyck, Mette Schrøder